Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Indivior ( (INDV) ) has shared an update.
Indivior PLC has announced a change in its major holdings, as Barclays PLC has acquired or disposed of voting rights, resulting in a new total of 9.67% of voting rights in Indivior. This adjustment in holdings reflects Barclays’ strategic financial maneuvers and could influence Indivior’s shareholder dynamics, potentially impacting its market position and stakeholder interests.
More about Indivior
Indivior PLC is a UK-based pharmaceutical company that specializes in developing and marketing medications for the treatment of addiction and its co-occurring disorders. The company focuses on providing innovative treatments to improve the lives of patients struggling with addiction, particularly opioid dependence.
For detailed information about INDV stock, go to TipRanks’ Stock Analysis page.